Slide 1

745 / 1631

Most AEs were grade 1 or 2.1
There were low rates of grade
3 and 4 adverse events.1
• The rate of grade 3 bleeding
events was 4.5%, there were no
grade 4 or 5 events1
• The most common infection of
grade ≥3 was pneumonia (6%)1
Phase II study
Adverse event profile
.
1. Wang M et al. N Engl J Med 2013; 369: 507-516.
Adverse events (AEs) reported in ≥15% of MCL patients1
* Febrile neutropaenia 2.7%